For those who aren't disgusted with AI, a straight
Post# of 157707

Why would Cytodyn present at the HC Wainwright investment conference
CytoDyn is presenting at the H.C. Wainwright investment conference
to attract potential investors, showcase recent developments in its lead drug leronlimab, and increase its visibility within the financial community. For a clinical-stage biotech company like CytoDyn, which currently has no product revenue, these conferences are critical for raising capital and building relationships.

